Nasdaq Delisting Threat Lifted as Elite Express Regains Compliance
ETS has more than doubled off its 52-week low of $0.39 on light trading volume (0.3× avg).
Summary
On August 6, 2026, Elite Express received Nasdaq confirmation that it has regained compliance with the minimum bid price rule, closing the delisting matter that began in October 2025.
Key Events · Legal and Risk Events · ETS
-
Nasdaq Compliance Regained
Nasdaq notified the company on August 6, 2026 that it has regained compliance with the Minimum Bid Price Requirement after maintaining a closing bid price of at least $1.00 for 10 consecutive business days, and the matter is now closed.
-
Delisting Risk Removed
The compliance determination eliminates the immediate threat of delisting that had been pending since October 2025, when the stock first fell below $1.00. The company had been operating under an extended deadline of October 26, 2026.
-
Stock Price Buffer
With the stock currently at $1.19, the company has a modest cushion above the $1.00 threshold, though it remains vulnerable to price declines given recent financial challenges.
-
Prior Financial Weakness
The compliance news comes after a $2.53M quarterly loss, a material weakness disclosure, and a highly dilutive $8M private placement, all of which had pressured the stock and raised delisting concerns.
Analysis · ETS · Energy & Transportation
Nasdaq has formally closed the minimum bid price deficiency matter after the stock held above $1.00 for 10 consecutive business days. This removes the immediate delisting risk that had been hanging over the company since October 2025—a critical development given the recent quarterly loss, material weakness, and dilutive financing. The stock now trades at $1.19, providing a buffer above the $1.00 threshold.
At the time of this filing, ETS was trading at $1.19 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $56.5M. The 52-week trading range was $0.39 to $4.23. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.